Navigation Links
Data From LigoCyte's Clinical Studies of Norovirus VLP Vaccine Presented at 13th Annual Conference on Vaccine Research
Date:4/28/2010

y environments, particularly hospitals, hotels, schools, and nursing homes, resulting in significant risk to immunocompromised individuals and mounting socioeconomic cost to families, the health care system and businesses. Military units are also affected, as outbreaks represent a significant readiness issue for naval vessels and land-based installations.

About LigoCyte's Norovirus Vaccine Candidate

LigoCyte's norovirus vaccine is a needle-free, dry powder formulation based on virus-like particle (VLP) antigens, which are highly purified protein products. By preserving the authentic conformation of the viral capsid, VLPs mimic the antigen presentation of the live virus while lacking the ability to reproduce or cause illness. LigoCyte's vaccine formulation also includes the adjuvant Monophosphoryl Lipid A, provided under license from GlaxoSmithKline (NYSE: GSK), and chitosan (ChiSys®) to enhance nasal delivery, under license from Archimedes Development Ltd. LigoCyte's challenge study will utilize a live Norwalk virus inoculum developed at Baylor College of Medicine with funding from the National Institutes of Health. Additional information about the study can be found at www.clinicaltrials.gov.

About the Vaccine Research Conference

The Annual Conference on Vaccine Research provides current, high-quality reports of scientific progress featured in both invited presentations and submitted abstracts. The wide range of topics, covered in both human and veterinary vaccinology,
'/>"/>

SOURCE LigoCyte Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioMedix Receives Clinical Approval for TRAKnet Software
2. Lexicon to Present Phase 2 Clinical Data for IBS Drug Candidate at Digestive Disease Week
3. Suzie Williams, CP Joins Orthocare Innovations as Clinical Services Manager
4. Kristalose(R) Clinical Data to Be Presented at Digestive Disease Week(R) Meeting
5. Curemark Adds UC Davis MIND Institute to Autism Clinical Trial Sites
6. AFFiRiS AG: Alzheimers Vaccine AD02 Already in Clinical Phase II
7. Gelesis Unveils Novel Non-Invasive Capsulated Device for Obesity and Presents Clinical Data; Appoints Former Pfizer R&D President to Board
8. PharmaMar Presents New Clinical Trials With Three Marine-Based Drugs at the American Association for Cancer Research Convention
9. Portola Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of PRT062607, an Oral, Syk-Specific Inhibitor for Chronic Inflammatory Disease Indications
10. Creating Healthcare Reform from the Inside Out Through Supply Chain Best Practices that Improve Financial and Clinical Performance is Focus of 2010 GHX Supply Chain Summit
11. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... SAN FRANCISCO , May 5, 2015  IQPC,s ... is pleased to announce the chairman of the Summit Mr. ... at Wipro. He will be joined by the expert speaker ... and more this May 11 – 12, at The Hotel ... The agenda is available for download on the event ...
(Date:5/5/2015)... Lymphatic pump treatment (LPT) shows promise in managing pneumonia ... study published in The Journal of the American ... on infected rats three times a day followed by ... pneumonia. After 96 hours, over 60 percent of the ... of rats who received levofloxacin alone. Commonly ...
(Date:5/5/2015)...  Kewaunee Scientific Corporation (NASDAQ: KEQU ) announced today ... Scientific,s Board of Directors, effective April 29, 2015. Mr. Gehl ... . The election of Mr. Gehl is in ... Board of his intention to resign from the Board, effective ... his election, Mr. Gehl was also elected chair of the ...
Breaking Medicine Technology:Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco 2Lymphatic Pump Treatment Enhances Antibiotic Effectiveness for Treating Pneumonia 2Keith M. Gehl Elected to Kewaunee Scientific Board of Directors 2Keith M. Gehl Elected to Kewaunee Scientific Board of Directors 3
... XTENT, Inc.,(Nasdaq: XTNT ) today announced that ... was published in the most recent issue of the,peer-reviewed ... Pieter R. Stella, M.D., of University Medical Center Utrecht, ... from 13 clinical,sites across Europe., The one-year CUSTOM ...
... Lead to New Prevention and Treatment Strategies--, PHILADELPHIA, ... the main cause of the inherited version,of the childhood ... mutations play a significant role in high-risk forms of,non-inherited ... "This discovery enables us to offer the first genetic ...
Cached Medicine Technology:XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Gene That Causes Childhood Cancer Neuroblastoma Is Found 2Gene That Causes Childhood Cancer Neuroblastoma Is Found 3Gene That Causes Childhood Cancer Neuroblastoma Is Found 4
(Date:5/5/2015)... The 2015 Crystal Ball, hosted by the Hepatitis B ... and patient advocacy programs. The gala evening included dancing, a ... of supporters. , The 2015 gala was dedicated to the ... (HBV) by Dr. Baruch S. Blumberg, who passed away in ... his discovery of the virus in 1976. He and his ...
(Date:5/5/2015)... 05, 2015 Viverae®, a health ... Inc., a leading multinational developer, manufacturer and marketer ... of vascular, urology, oncology and surgical specialty products, ... The Vanguard Award recognizes outstanding achievement in ... among Viverae’s significant client base. , Viverae reviewed ...
(Date:5/5/2015)... 05, 2015 Sunny skies and cool temperatures ... as nearly 400 runners and walkers participated in Global Lyme ... nearly $35,000. , The 5K and 10K runs and ... disease and to raise funds for tick-borne disease research. The ... the recent merger of Lyme Research Alliance (LRA) ...
(Date:5/5/2015)... Skedans Systems a division ... the Skedans Sensor Collaboration Platform at AUVSI's Unmanned ... app developers, provides tooling to deliver real time information ... The Skedans Sensor Collaboration Platform is a single unified ... of Things, Web Real Time Communications (WebRTC), and commercial ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 This year, ... Medals, four Special Merit Awards, three Gold Medals and ... projects are described as follows: , (1) Grand Prize ... Robotic Mannequin for Fashion Design and Fitting, Principal Investigator: ... , The apparel industry relies very much on the ...
Breaking Medicine News(10 mins):Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 2Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 3Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 3Health News:PolyU wins top prizes in Geneva’s Invention Expo 4Health News:PolyU wins top prizes in Geneva’s Invention Expo 5
... University of Warwick have taken inspiration from corkscrew structures found ... against infections like E-coli and MRSA. , Researchers have created ... could be a key tool in the worldwide battle against ... have created what they term ,flexicates, which are active against ...
... , FRIDAY, Nov. 25 (HealthDay News) -- Patients ... disease, may be at greater risk for a life-threatening pulmonary ... a new study finds. Reporting online Nov. 25 in ... taken to prevent this condition among patients admitted to the ...
... imaging (fMRI), researchers have identified abnormalities in the brains ... serve as a biomarker for the disorder, according to ... the Radiological Society of North America (RSNA). ADHD ... an estimated five to eight percent of school-aged children. ...
... THURSDAY, Nov. 24 (HealthDay News) -- Higher doses of ... people suffering from aggressive lymphomas, such as diffuse large ... forms of non-Hodgkin,s lymphoma), according to new research. ... Lancet found this intensive form of chemotherapy, when ...
... FRIDAY, Nov. 25 (HealthDay News) -- Yawning helps keep the ... process by acting as bellows, a new report suggests. ... Rather, yawning helps regulate the brain,s temperature, according to Gary ... Andrew Gallup, of Princeton University. "The brain is exquisitely ...
... should be able to choose where they give birth, concludes ... first-time mums who opt for a home birth are at ... low in all birth settings. The researchers say their ... pregnancies a choice of birth setting" and will enable women ...
Cached Medicine News:Health News:'Left-handed iron corkscrews' point the way to new weapon in battle against superbugs like MRSA 2Health News:Autoimmune Woes May Raise Risk for Lung Clots 2Health News:Functional brain pathways disrupted in children with ADHD 2Health News:More Aggressive Chemo May Help Younger Lymphoma Patients: Study 2Health News:More Aggressive Chemo May Help Younger Lymphoma Patients: Study 3Health News:Yawning May Cool the Brain When Needed 2Health News:Pregnant women at low risk of complications can safely be offered a choice of where to give birth 2
For use in cleaning soft contact lenses. Sensitive Eyes daily cleaner loosens and removes accumulations of film, deposits, and debris from soft contact lenses. Use with heat, chemical, and hydrogen p...
Refresh Contacts provides moisturizing relief from dryness and irritation associated with lens wear....
Specially formulated to lubricate and moisten lenses to help relieve irritation and dryness....
... Renu Multiplus preservative free ... and moisturize your eyes while ... The gentle preservative free formula ... may be sensitive to preservatives ...
Medicine Products: